2021
DOI: 10.1016/j.jval.2021.04.293
|View full text |Cite
|
Sign up to set email alerts
|

PCN202 Use of Restricted Mean Survival Time in the Presence of Non-Proportional Hazards As an Alternative Measure of Treatment Benefit in Cost-Effectiveness Analyses

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles